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Abstract
80 patients with gastroesophageal reflux disease (GERD) were examined. The diagnosis of GERD was based on the his-
tory of the disease, complaints of patients, the results of daily monitoring of pH in the lower third of the esophagus, data of fi-
broesophagogastroduodenoscopy, chromoendoscopy, 13C-octanoic breath test, gastrin-17 (G-17) concentration, pepsinogens I and II 
(P I and II) and cholecystokinin-pancreozymin (C-P) in serum.
After 24 hours pH monitoring of the lower third of the esophagus in 40 patients with GERD, the predominance of acid was 
found, and the other 40 patients had mixed refluxes. In patients with predominance of acid reflux, the mean values of half-life of solid 
food evaluation (T1/2) according to 13C-octanoic breath test was (45.25±1.34) min. With the predominance of mixed refluxes in pa-
tients, there was a tendency towards hypokinetic motility of the stomach, indicating a slowdown in half-life of solid food evaluation 
from the stomach up to (139.24±11.87) min. With the predominance of acid reflux also was observed a significant reduction in the 
concentration of G-17 and C-P, an increase in P I and a decrease in the concentration of P II. Hypergastrinemia, high levels of C-P 
and P II (37.44±3.41) μg/l (p<0,05) were diagnosed with the predominance of mixed refluxes.
Keywords: gastroesophageal reflux disease, 24 hours pH monitoring of the lower third of the esophagus, 13C-octanoic 
breath test, gastropanel, cholecystokinin-pancreozymin.
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1. Introduction
Gastroesophageal reflux disease (GERD) is a multifactorial disease, the occurrence of which 
is important as a contributing factor, among which stress, work associated with inclining, obesity, 
smoking, some medication, nutrition, and determinative factors, which include cardiac failure, re-
flux of gastric and duodenal contents, decreased esophageal clearance and resistance of the mucous 
membrane of the esophagus [1, 2].
A significant number of exogenous and endogenous factors influences the tonus of the low-
er esophageal sphincter [3, 4]. In particular, the pressure in it decreases under the influence of a 
number of gastrointestinal hormones: glucagon, gastrin, somatostatin, cholecystokinin, secretin, 
vasointestinal peptide, enkephalin [5, 6]. Reducing the tonus of the lower esophageal sphincter may 
also be due to a violation of receptor sensitivity to gastrin, both at the periphery and in the central 
nervous system [7, 8]. Due to the violation of regulatory mechanisms that coordinate the periodic 
motor activity of the gastrointestinal tract, there is a disintegration of the secondary peristalsis of 
the esophagus, dysfunction of the lower esophagus and pyloric sphincter, increasement of intragas-
tric and intraduodenal pressure [9]. 
2. Aim of research
To study the nature of changes in the motor-evacuation function of the stomach and indi-
cators of 24 hours pH monitoring in the lower third of the esophagus, to establish the role of gas-
trin-17, cholecystokinin- pancreozymin, changes in the level of pepsinogens and their correlation 
in the pathogenesis of gastroesophageal reflux disease.
3. Materials and methods
The work was performed at the Department of general practice (Family medicine), physical 
rehabilitation and sports medicine of the Ivano-Frankivsk National Medical University, for the 
period 2014–2016. 80 patients with GERD were examined. The age of the patients varied from 
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19 to 73 years and amounted to an average of 45.88±1.32 years, the mean duration of GERD was 
6.67±1.07 years.
The main verifying method in the diagnosis of GERD is fibroesophagogastroduodenoscopy 
(FEGD) according to the generally accepted method using the “Olympus” apparatus GIF-XPE. In 
establishing the clinical diagnosis of GERD, the degree of damage to the esophagus was deter-
mined after an endoscopic examination (A, B, C, D), according to the Los Angeles classification 
[10]. Among the additional endoscopic diagnostic methods, the most accessible and informative 
was the chromoscopy with the use of dye (Lugol solution) [11].
The statistical processing of the obtained results was carried out using the software – Mi-
crosoft Excel spreadsheet and application package Statistica v. 10.0 StatSoft, USA. Estimation of 
the probability of divergence of mean values of the conducts using the dual t-criterion of Student.
Experimental procedures
Daily (24-hour) esophageal pH. The method allowed to quantify the frequency, duration 
and daily dynamics of gastroesophageal and gastroduodenal reflux, the number and duration of 
episodes of pH <4 and >7 in the esophagus. Lower esophageal pH monitoring in the night and day 
periods was performed by acidogastrograph AG-1rN-M. The night period was determined from the 
time when the patient lay in bed to fall asleep until the morning when he woke up. In the analysis 
of daily monitoring of pH in the lower third of the esophagus, we evaluated the measurements of 
the DeMeester scale.
The motor-evacuation function of the stomach was examined using the 13C-octanoic breath 
test. The air analysis was carried out on IRIS (Wagner-Analysen-Technic, Germany) infrared anal-
yser. A concentration curve of 13CO2 was constructed and the half-life of solid food from the stom-
ach in minutes (T
1/2
) and the drainage factor (GEC) were calculated.
Research of the concentration of gastrin, pepsinogen I and II in the blood was carried out 
on the basis of the GasroPanelBIOHIT (Finland) test system. The basis of the technology of the 
panel “GasroPanel” is the principle of enzyme-linked immunosorbent assay (ELISA). The special 
ELISA equipment of the company “VIONIT” allowed to measure the level of pepsinogens I and II, 
gastrin-17. Investigation of the concentration of cholecystokinin-pancreozymin in serum was per-
formed by the enzyme-linked immunosorbent method, using “Peninsula Laboratories Inc” (USA) 
and expressed in ng/ml.
4. Results
Young patients (16-29 years of age) were more likely to have an A-B degree of esophagitis 
than C-D (χ2=2.571; p>0.05), while people over 60 years of age were more likely to have a degree of 
C-D (in 3 out of 5 cases; χ2=0.171; p>0.05). At the age of 30-59, B than A, C and D was significantly 
more likely to be diagnosed (χ2=6.332; p<0.05; χ2=3.741; p>0.05; χ2=12.692; p<0.001). At the dura-
tion of GERD 1–5 years, the stages A (10.00 %) and B (5.00 %) – χ2=4.000 were significantly more 
often diagnosed; p<0.05. At the duration of the disease up to 10 years, a tendency towards the pro-
gression of the esophagitis is noted: stage B is diagnosed at 22,50 %, and C – at 17,50 %, which has 
been significantly more developed in compared to the duration of the disease to 5 years (χ2=10.329; 
p<0.01). In patients with a long history of GERD (>10 years), the stages of C-D (χ2=8,526; p<0.01) 
were significantly more often established.
Two cases of Barrett’s esophagus were detected and histologically verified with the chro-
moeozofagoendoscopy. These patients were subsequently excluded from the study.
After 24-hours pH monitoring in the lower third of the esophagus in 40 patients with GERD, 
the predominance of acid was found, and in the other 40 patients were detected mixed refluxes.
The peculiarities of the daily pH analysis with the predominance of acid refluxes 
were: the mean value of the intra-esophageal pH (4.58±0.33) (pH min – pH max, respective-
ly, 1.64±0.23 – 6.45±0.52), indicating about a stable acid aggression of the lower third of the 
esophagus. In 77.50 % of patients, the persistent predominance of acid reflux with average 
values (3.22±0.15) was established. At 15.00 %, respectively, the average values of the intra-
vascular pH were (4.78±0.36), and 7.50 % – (7.08±0.42). The average time of throwing aggres-
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sive gastric juice was 1 hour per day (77.24±5.14) min. The average number of acid episodes of 
>5 min was 57.
Often, acidic refluxes were recorded in the first half of the night (7.28±0.64). In the up-
right position of the body, the acidity of the lower third of the esophagus was observed during 
(8.24±0.75) min, often these episodes of long-term acid reflux were observed after ingestion of fat 
or use of large portions of food. In patients with predominance of acid reflux, the DeMeester index 
was (28.78±0.18) (normally up to 14.72).
With the predominance of mixed reflux in patients with GERD, the mean intra-invasive pH 
value with a tendency toward neutral indices (5.69±0.29) was statistically significant (p1<0.001). 
The variation of the minimum and maximum values of the esophagus pH was (3.01±0.12) – 
(7.89±0.66), respectively.
Such values are evidently due to the presence of duodenal and biliary content in the esoph-
agus. Total daily time, when in the lower third of the esophagus, the pH <4.0 was less than an 
hour (44.84±2.07) min (p1<0.01), however, the time of contact of the lower third of the esophagus 
with alkaline contents of the pH>7.0 (75.25±0.61) min (p1<0.001). The total DeMeester mean was 
(18.87±0.09) (p1<0.01).
According to the results of the 13C-octanoic breath test in the examined patients, in the prac-
tically healthy people, the half-life of food (T
1/2
) from the stomach was (64.69±2.17) min, and the 
drainage factor (GEC) – (3.97±0.03). In patients with predominance of acid reflux, according to dai-
ly monitoring of pH in the lower third of the esophagus, the mean values of the 13C-octanoic breath 
test were T
1/2
 – (45.25±1.34) min, p <0.05 and GEC (4.15±0.13, p<0.05, indicating the predominance 
of the hypermotor type of gastric contractility and excessively accelerated evacuation of food.
With the predominance of mixed refluxes in patients, there was a tendency toward hypoki-
netic motility of the stomach, indicating a slowdown T
1/2
 to (139.24±11.87) min, as compared with 
healthy (p<0.05), and with patients in which determined the dominance of acid refluxes (p1<0.05), 
and a significant decrease in GEC – (2.12±0.19) (p<0.05; p1<0.05).
All patients with GERD have been tested for the content of gastrin-17, cholecystokinin-pan-
creozymin, pepsinogen-I and pepsinogen-II [12]. They have a multidirectional change in hormonal 
secretion and motor-evacuation function of the lower part of the esophagus, stomach and sphincter 
apparatus.
With the predominance of acid reflux, a significant reduction in the concentration of T-17 
with mean values (4.28±0.21) pmol/l (p<0.05) and C-P (3.25±0.17) ng/ml (p<0.05), a rise in P I to 
(375.18±15.25) μg/l (p<0.05), and a decrease in the concentration of P II to (15.12±1.24) μg/l (p> 
0,05) and increase the ratio of P I/P II to (22.83±1.89) of cond. units. Instead, with the predominance 
of mixed reflux, hypergastrinemia (24.28±1.87) pmol/l (p<0.05), high level of C-P (7.27±0.42) ng/
ml (p<0.05) and PII (37.44±3.41) μg/l (p<0.05). In these patients, the concentration of P I tended to 
decrease but did not significantly differ from healthy subjects (112.27±8.74) μg/l (p>0.05), although 
there was a significant decrease in the P I /P II ratio to (5.57±0.47) of the cond. units (p<0.05).
5. Discussion
In patients with predominance of acid reflux, the accelerated evacuation of the stomach is 
likely to indicate a dyskinetic prolapse and propulsion through the lower diaphragmatic sphincter 
and the ingestion of aggressive acidic contents in the stomach.
In 70 % of patients with GERD with predominance of acid reflux hypertonic-hyperkinetic 
type of motor-evacuation function of the stomach is noted. This is also evidenced by the presence 
of a direct strong correlation between T
1/2 
and the pH mean in the lower part of the esophagus 
(r=0.85; p<0.001) and GEC pH (r=0.79; p<0.001). Normal kinetic and hypokinetic motility of the 
stomach was observed rarely. Therefore, it should be considered that in patients with a combination 
of hyperkinetic state of motility and prolonged acid reflux in the esophagus, the acid component 
itself plays a leading role in the progression of the disease, which causes the need for higher doses 
of antacids. Instead, according to the results of our own studies, it was found that in patients with 
frequent and prolonged alkaline reflux, the hypotonic-hypokinetic type (57.5 %) was characteristic, 
as evidenced by the presence of the average strength of a direct correlation between T
1/2 
and the 
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prevalence of alkaline esophagitis pH (r=0.62; p<0.01) and GEC and pH (r=0.68; p<0.01). Also, 
one out of five patients did not have a significant gastrointestinal motility disorder. In our opin-
ion, structural changes in SOS are due to the damaging effects of the acidic component and the 
long stasis in the stomach and the remitting of retrograde duodenal contents containing bile acids. 
Therefore, before treatment in such patients, it is appropriate to attach a prokinetic drug and an 
agent that would neutralize the biliary component of the reflux.
After analysis of the correlation of blood T-17 concentration with the 24-hours pH monitor-
ing of the lower part of the esophagus using the odds ratio method, it was found that in patients with 
low levels, acid reflux with pH ranged from 3.0 to 3.99 (OR=8.69; p=0.04) and with pH 2.0–2.99 
(OR=7.43; p=0.02) and somewhat less frequently from pH 1.0–1.99 (OR=3.0; p=0.03). (not indicated 
in the presented article). Most often (23.4±2.4) cases in the lower third of the esophagus were re-
corded pH in the range of 2.0–2.99, less (15.4±1.6) cases per day - with pH 3.0-3.99. In patients with 
GERD in (8.9±1.9) cases per day, reflux was found to be too acidic with pH in the range of 1.0–1.99. 
The alkaline reflux in patients with GERD with a low level of gastrin in serum is not registered.
In subjects with elevated level G-17, the results of daily monitoring of the pH of the lower 
third of the esophagus were more often recorded alkaline reflux with pH in the range of 7.0–7.99 
(OR=2.6; p=0.04), the total number of which was (15.5±2.1) episodes per day (p <0.05), whereas 
at normal level of T-17 only in (2.3±0.4) cases. Also in patients with GERD with high level of T-17 
blood in (6.2±1.1) cases in the lower third of the esophagus, the pH was determined in the range 
of 8.0–8.5, in the absence of episodes of such ingestion in patients with normal and lowered level 
G-17. This fact can be explained by the stimulating effect of gastrin on peristalsis of the gastroin-
testinal tract. G-17 induces secretin secretion, and C-P, consequently, enhances the secretion of bile 
and pancreatic secretion that is thrown into the stomach and esophagus. C-P also stimulates the 
secretion of the gastric secretion, suppresses its evacuation, and relaxes the Oddi sphincter.
After analysing the relationship between the level of T-17 in the blood, the duration of 
GERD, it was found that in patients with a long history of disease to one and from one to five 
years of age, its serum concentration did not differ and equalled, respectively (5.41±1.12) pmol/l 
and (7.33±1.40) pmol/l (p>0.05). In 75.50 % of patients with GERD with a history of the disease 
>5 years, the concentration of G-17 was (20.55±3.10) pmol/l, exceeding the indexes of the first du-
ration of the disease by 3.8 and 2.8 times (p1,2<0.05).
The emergence of pathological gastroesophageal reflux is largely dependent on the disturbed 
motility of the stomach and duodenum [13, 14], while the infection and eradication of Helicobacter 
Pylory do not play an important role in the genesis of GERD, which is also noted in the 4 Maastricht 
consensus. In addition, the discoordination of the motor-evacuator function of the upper parts of 
the gastrointestinal tract, in particular the stomach, is the basis for the appearance of mixed (duo-
denal refluxes), due to the imbalance in the contractile activity of the antral and pyloric divisions 
and the duodenum [15, 16]. The rate of reduction of the stomach also depends on the level of some 
gastrointestinal hormones, in particular, ghrelin (a direct biochemical predictor of this process) and 
gastrin [17, 18]. Reducing the tone of the stomach and slowing the evacuation period from it is often 
combined with the increased contractile capacity of the duodenum and the appearance of duodeno-
gastric and gastroesophageal reflux and the development of GERD [19, 20]. In addition, there is a 
certain correlation between the appearance of such refluxes with the function of gastric receptors, 
especially as gastrin enhances motor function of the stomach. 
6. Conclusions
1. In gastroesophageal reflux disease, A (23.75 %), B (37.50 %), and C (25.00 %) degrees 
of esophagitis, according to the Los Angeles Endoscopic Classification, were predominantly 
diagnosed.
2. According to 24-hours pH monitoring of the lower third of the esophagus, patients 
with gastroesophageal reflux disease with almost identical frequency recorded acid and mixed 
reflux. The number of episodes of acid regurgitation was 57 cases, the retention time of pH<4 – 
(77.24±5.14) min per day. The frequency of reflux mixed with a pH>7 was 9 cases, respectively, and 
their duration – (75.25±0.61) min per day.
Original Research Article:
full paper
(2018), «EUREKA: Health Sciences»
Number 1
7
Medicine and Dentistry
3. In cases of prevalence of acidic esophageal reflux, an increase in contractional function 
of the stomach was observed with T
1/2 
(45.25±1.34) min (p<0.05), and in case of mixed reflux there 
was a slowed-down type of T
1/2
 (139.24±11.87) min (p <0,05).
4. In patients with gastroesophageal reflux disease with a low level of gastrin-17 in serum, 
acidic reflux was found to prevail from pH 3.00–3.99 (OR=8.69; p=0.04), pH 2.00–2.99 (OR=7.43; 
p=0.02), and pH 1.00–1.99 (OR=3.0; p=0.03), and for increasing its concentration, mixed reflux was 
recorded with pH at intervals of 7.00–7.99 (OR=2.6, p=0.04). 
5. In patients with gastroesophageal reflux disease, with the predominance of acid reflux, 
the concentration of pepsinogen I in the blood was 3.5 times higher than in healthy subjects, and 
the level of pepsinogen II did not differ from the norm with increasing their ratio, and with the pre-
dominance of mixed – the concentration of pepsingogen I in the blood was within the normal range 
with an increase in the level of pepsinogen II to (37.44±3.41) μg/l and a decrease in their ratio to 
(5.57±0.47) cond. unit.
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